StockData
Savara Inc logo

Savara Inc (SVRA) stock

SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.48+0.02 (+0.34%)

Close on Nov 17, 2026Market cap $920.46MP/E –Yield –

Savara ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Savara's ebitda for the twelve months ending Jun 30, 2026 was -$143.55M. For fiscal 2025 it was -$123.46M. The highest annual figure on record is -$5.78M in fiscal 2015.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$123.46M–
FY2024Dec 31, 2024-$103.07M–
FY2023Dec 31, 2023-$59.93M–
FY2022Dec 31, 2022-$38.81M–
FY2021Dec 31, 2021-$41.34M–
FY2020Dec 31, 2020-$49.05M–
FY2019Dec 31, 2019-$78.71M–
FY2018Dec 31, 2018-$69.52M–
FY2016Dec 31, 2016-$10.85M–
FY2015Dec 31, 2015-$5.78M–
FY2014Dec 31, 2014-$29.19M–
FY2013Dec 31, 2013-$21.50M–
FY2012Dec 31, 2012-$15.54M–
FY2011Dec 31, 2011-$13.36M–
FY2010Dec 31, 2010-$8.52M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$40.94M–
Q1 FY2026Mar 31, 2026-$38.97M–
Q4 FY2025Dec 31, 2025-$33.43M–
Q3 FY2025Sep 30, 2025-$30.22M–
Q2 FY2025Jun 30, 2025-$31.41M–
Q1 FY2025Mar 31, 2025-$28.41M–
Q4 FY2024Dec 31, 2024-$31.14M–
Q3 FY2024Sep 30, 2024-$26.32M–
Q2 FY2024Jun 30, 2024-$23.16M–
Q1 FY2024Mar 31, 2024-$22.44M–
Q4 FY2023Dec 31, 2023-$17.60M–
Q3 FY2023Sep 30, 2023-$18.01M–
Q2 FY2023Jun 30, 2023-$12.21M–
Q1 FY2023Mar 31, 2023-$12.10M–
Q4 FY2022Dec 31, 2022-$10.87M–
Q3 FY2022Sep 30, 2022-$10.53M–
Q2 FY2022Jun 30, 2022-$9.38M–
Q1 FY2022Mar 31, 2022-$8.04M–
Q4 FY2021Dec 31, 2021-$10.64M–
Q3 FY2021Sep 30, 2021-$9.93M–
Q2 FY2021Jun 30, 2021-$10.41M–
Q1 FY2021Mar 31, 2021-$10.37M–
Q4 FY2020Dec 31, 2020-$12.95M–
Q3 FY2020Sep 30, 2020-$10.72M–
Q2 FY2020Jun 30, 2020-$9.20M–
Q1 FY2020Mar 31, 2020-$16.18M–
Q4 FY2019Dec 31, 2019-$31.45M–
Q3 FY2019Sep 30, 2019-$12.39M–
Q2 FY2019Jun 30, 2019-$22.10M–
Q1 FY2019Mar 31, 2019-$12.61M–
Q4 FY2018Dec 31, 2018-$13.11M–
Q3 FY2018Sep 30, 2018-$12.66M–
Q2 FY2018Jun 30, 2018-$11.75M–
Q1 FY2018Mar 31, 2018-$32.00M–
Q1 FY2017Mar 31, 2017-$4.76M–
Q4 FY2016Dec 31, 2016-$4.03M–
Q3 FY2016Sep 30, 2016-$3.21M–

More Savara figures

See a number that looks wrong?